Compounds > 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone
Page last updated: 2024-11-03

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Anterior Circulation Transient Ischemic Attack

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with Anterior Circulation Transient Ischemic Attack in 2 studies

4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone: Inhibitor of phosphodiesterases.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flamm, ES2
Kim, J2
Lin, J2
Ransohoff, J2

Other Studies

2 other studies available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Anterior Circulation Transient Ischemic Attack

ArticleYear
Phosphodiesterase inhibitors and cerebral vasospasm.
    Archives of neurology, 1975, Volume: 32, Issue:8

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Administration, Topical; Aminophylline; Animals; Cat

1975
Phosphodiesterase inhibitors and cerebral vasospasm.
    Transactions of the American Neurological Association, 1974, Volume: 99

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Aminophylline; Animals; Cats; Haplorhini; Ischemic A

1974